Comments on a study which examined how a molecular automata might be used to augment so-called antisense technologies, carrying out a diagnosis in vivo that automatically controls drug delivery. Conditional release of antisense drugs; Diagnostic molecule structure used to enclose the drug; Formation of duplex between two oligonucleotides.